Use of selexipag in a child with pulmonary hypertension associated with sickle cell disease

J Heart Lung Transplant. 2020 Sep;39(9):990-993. doi: 10.1016/j.healun.2020.04.022. Epub 2020 Apr 29.

Authors

Bibhuti B Das¹, Michelle Marie Jadotte², Kak-Chen Chan²

Affiliations

¹ Joe DiMaggio Children's Hospital Heart institute, Memorial Healthcare, Hollywood, Florida; Department of Pediatric Cardiology, Baylor College of Medicine, Texas Children's Hospital, Specialty Care Clinic, Austin, Texas. Electronic address: bdas99@hotmail.com.
² Joe DiMaggio Children's Hospital Heart institute, Memorial Healthcare, Hollywood, Florida.

PMID: 32418865
DOI: 10.1016/j.healun.2020.04.022

No abstract available

Publication types

Case Reports

MeSH terms

Acetamides / therapeutic use*
Anemia, Sickle Cell / complications*
Antihypertensive Agents / therapeutic use
Child
Female
Humans
Hypertension, Pulmonary / drug therapy*
Hypertension, Pulmonary / etiology
Hypertension, Pulmonary / physiopathology
Prodrugs
Pulmonary Wedge Pressure / drug effects*
Pyrazines / therapeutic use*

Substances

Acetamides
Antihypertensive Agents
Prodrugs
Pyrazines
selexipag